Magnetically-enhanced radionuclide therapy (MERiT): In vitro evaluation
- 15 March 1997
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 37 (5) , 1201-1206
- https://doi.org/10.1016/s0360-3016(96)00616-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Exposure to strong static magnetic field slows the growth of human cancer cells in vitroBioelectromagnetics, 1996
- The effects of static 3.0 T and 0.5 T magnetic fields and the echo-planar imaging experiment at 0.5 T on E. coliThe British Journal of Radiology, 1994
- Backbone-substituted DTPA ligands for yttrium-90 radioimmunotherapyBioconjugate Chemistry, 1991
- Antibody targeted therapy in cancer: comparison of murine and clinical studiesCancer Treatment Reviews, 1990
- Monoclonal antibodies for imaging and therapyBritish Journal of Cancer, 1989
- 212Bismuth Linked to an Antipancreatic Carcinoma Antibody: Model for Alpha-Particle-Emitter RadioimmunotherapyJNCI Journal of the National Cancer Institute, 1988
- A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumorsCancer, 1988
- Influence of magnetic fields on the response of acrylic scintillatorsNuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 1987
- ANTIBODY-GUIDED RADIATION THERAPY VIA THE CSF FOR MALIGNANT MENINGITISThe Lancet, 1986
- Monoclonal antibodies: Potential role in radiation therapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1982